Reuters logo
BRIEF-Revance Plans Phase 3 Program For RT002 Injectable To Treat Cervical Dystonia
November 29, 2017 / 9:14 PM / 15 days ago

BRIEF-Revance Plans Phase 3 Program For RT002 Injectable To Treat Cervical Dystonia

Nov 29 (Reuters) - Revance Therapeutics Inc:

* REVANCE PLANS PHASE 3 PROGRAM FOR RT002 INJECTABLE TO TREAT CERVICAL DYSTONIA

* REVANCE THERAPEUTICS INC - COMPANY COMPLETES END-OF-PHASE 2 MEETING WITH FDA

* REVANCE THERAPEUTICS - FINALIZING TRIAL PROTOCOLS FOR PIVOTAL RT002 PROGRAM, WHICH IS PLANNED TO COMMENCE IN Q2 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below